Shares of the Molecular Data Inc. (MKD) stock rose in the Pre-market today on September 24, 2021. MKD stock price saw a push of 3.78% to reach $0.31 a share at the time of this writing. It seems that Molecular stock is continuing the rising momentum as it went up by 5.17% at the previous closing. Let’s understand the reason behind this bull.
What’s Happening?
There seems to be no press release or specific news by Molecular Data in today’s date to support the ongoing rally. No analysts’ upgrades or increased targeted per share price of MKD stock has been reported recently. However, MKD stock closed $15 million registered direct offering a couple of days ago. The current bullish sentiment is due to the social media discussions between investors. Many investors think that this is the right time to buy this stock due to its low per-share price. For your intuition, let’s discuss some recent events of this stock.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Molecular Data Inc, founded in 2013, runs the Chemical eCommerce business in the People’s Republic of China. It provides eCommerce solutions, warehousing, and logistics solutions, and financial solutions. Moreover, it also provides SaaS suites to the chemical industry.
MKD stock closed registered direct offering:
On September 22, 2021, Molecular Data announced the closing of a $15 million registered direct offering. The common units being offered consisted of one American Depositary Share, one warrant to purchase one ADS, and pre-funded units. The American depository shares consisted of three class A ordinary shares of MKD stock and pre-funded units consisted of one pre-funded warrant and one warrant to purchase one ADS. Pre-funded warrants and ADS warrants had an exercise price of $0.0001 and $0.38 respectively. The gross proceeds were $15 million without subtracting placement agent fees and offering related expenses. Molecular Data is planned to use net proceeds for working capital and general corporate purposes.
MKD stock Strengthen its Logistic Capabilities:
On September 13, 2021, MKD stock did announce the strategic partnership memorandum for a potential transaction, including a stake in a famous Chinese logistic player having profound experience in the respective domain. The collaboration will result in the deployment of the system in such a way so that the truck will dispatch accurately. The strengthened logistic system will remove the inadequacies thus results in increased logistic efficiency and low costs.
Conclusion:
Molecular Data stock is hot among investors so far, but it would be interesting to see how long it will persist. The history is not so much satisfactory for this stock as it lost 74% in the last 12 months and 63% year to date. Hence deep research is better before taking any step.
